Bayer to invest 2 bln euros in drug production over next 3 years
Published on: Wednesday 30 March 2022
German drugmaker Bayer said it would invest around 2 billion euros ($2.23 billion) at pharmaceutical manufacturing sites over the next three years, mainly to bolster production of biotechnology drugs as well as cell and gene therapies.
